tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market

Elite Pharmaceuticals (ELTP) Revenue

Compare
368 Followers

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had a revenue of 36.32M in the quarter ending Sep 30, 2025, with -9.67%. This bring the company's revenue in the last twelve months to 122.89M, Decreased 16.54%. In the fiscal year ending Dec 31, 2025, Elite Pharmaceuticals had annual revenue of 84.04M with 48.42% growth.
Revenue (ttm)
122.89M
Revenue Growth
72.67%
P/S Ratio
6.39
Revenue/Employee
$1,313,186
Employees
64
Market Cap
$537.14M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
84.04M27.42M+148.42%
Dec 31, 2024
56.63M-34.10B+0.17%
Dec 31, 2023
34.16B34.12B+105,867.56%
Dec 31, 2022
32.26M6.88M+127.11%
Dec 31, 2021
25.38M7.39M+141.05%
Dec 31, 2020
17.99M10.43M+237.76%
Dec 31, 2019
7.57M109.80K+101.47%
Dec 31, 2018
7.46M-2.18M+77.39%
Dec 31, 2017
9.64M-2.86M+77.11%
Dec 31, 2016
12.50M